Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Will the Fed Raise Interest Rates in the Coming Months? The Latest Forecasts Are Here

Will the Fed Raise Interest Rates in the Coming Months? The Latest Forecasts Are Here

BitcoinSistemiBitcoinSistemi2026/09/27 14:27

The continued resilience of employment and consumption in the US economy strengthens expectations that the Fed may keep interest rates at high levels for a longer period.

According to Bloomberg and Reuters surveys, economists expect non-farm payrolls in the US to increase by approximately 90,000 and 100,000 respectively in September. The unemployment rate is estimated to remain between 4.1% and 4.2%.

The strong performance in consumption is also expected to continue. According to Bloomberg’s forecast, real personal consumption expenditures in the US could increase by 0.5% on a monthly basis in August. If this forecast materializes, it would be the strongest monthly increase in over a year. The resilience in employment and consumption indicates that demand in the US economy has not yet cooled significantly, providing room for the Fed to maintain its tight monetary policy.

On the other hand, inflationary pressures remain a significant constraint for the Fed. The market expects both headline and core personal consumption expenditures (PCE) price indexes to accelerate their monthly growth in August. The annual growth in core personal consumption expenditures (PCE) previously stood at 3.3%, exceeding the Fed’s long-term inflation target of 2%.

The Fed raised its policy rate by 25 basis points this month, marking its first rate hike in three years, and signaled that further increases could be on the agenda later in the year. With recent economic data, market expectations are rising for another 25 basis point rate hike in October.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - US Stock Market Dynamics - RXO, Harley-Davidson, Vistra

Search string for querying individual stock trends in the workspace: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Brief" newsletter: https://refini.tv/3dKUyB8 Reuters, October 5 - On Monday, U.S. stock index futures edged lower as tech stocks retreated after reaching record highs. As Treasury yields and oil prices remain elevated, investors are seeking new clues about the direction of monetary policy. .N ** RXO RXO.N: Market focus — RXO shares rose following C.H. Robinson's announcement of a 5.8 billions USD acquisition plan nL6N45R0N4 ** Harley-Davidson HOG.N: Market focus — Citi upgraded Harley-Davidson to "Buy," shares climbed nL6N45R0M3 ** GEO Group GEO.N: Spotlight — GEO gained as it sold ICE facilities for 950 millions USD and expanded its stock buyback nL6N45R0MR ** Vistra VST.N: Spotlight — Vistra rallied as it was reportedly set to receive a 4.2 billions USD U.S. nuclear loan nL4N45R0L8 ** Vaxcyte PCVX.O: Spotlight — Vaxcyte surged after positive late-stage clinical trial data for its pneumococcal vaccine nL4N45R0K0 ** Estée Lauder EL.N: Spotlight — Barclays upgraded Estée Lauder to "Overweight," shares advanced nL6N45R0HX ** PTC PTC.O: Spotlight — Schneider Electric agreed to acquire PTC for 22.6 billions USD, shares jumped nL6N45R0HV (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automatic translation may contain errors or fail to convey the required context, Reuters does not guarantee the accuracy of automatically translated texts and provides them solely for readers’ convenience. Reuters accepts no liability for any damages or losses arising from the use of automated translation features.)

路透社•2026/10/05 12:06

BUZZ-Alector stock surges after agreement with Genentech on an experimental Parkinson's disease drug

October 5 - The stock price of pharmaceutical company Alector (ALEC.O) surged by 44.20% in pre-market trading, reaching $2.61. The company has entered into a global licensing agreement with Genentech for AL050, an experimental drug developed by ALEC for the treatment of Parkinson's disease. ALEC has granted Genentech the exclusive worldwide rights to develop and commercialize AL050. According to ALEC, the agreement will bring an upfront payment of $100 million and may result in milestone payments of up to $1.17 billion by 2029. The company retains ownership of its ABC technology platform for developing therapies for neurodegenerative diseases, as well as all rights to use the platform in its research and development pipeline. As of the close of the previous trading day, ALEC's stock price had risen by 16.03%. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Due to possible errors in automation or lack of context, Reuters does not guarantee the accuracy of the automated translation, which is provided solely for the convenience of readers. Reuters assumes no responsibility for any damage or loss caused by the use of the automated translation.)

路透社•2026/10/05 11:54